Page last updated: 2024-08-26

cv 6504 and thromboxane b2

cv 6504 has been researched along with thromboxane b2 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishikawa, K; Ohkawa, S; Shibouta, Y; Terao, S; Terashita, Z1
Anderson, DA; Baddeley, J; Bramhall, S; Buckels, J; Daryanani, S; Deakin, M; Doran, J; Ferry, DR; Kerr, DJ; Pemberton, G; Wakelam, MJ; Young, AM1

Trials

1 trial(s) available for cv 6504 and thromboxane b2

ArticleYear
A phase II study of the 5-lipoxygenase inhibitor, CV6504, in advanced pancreatic cancer: correlation of clinical data with pharmacokinetic and pharmacodynamic endpoints.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9

    Topics: Antineoplastic Agents; Benzoquinones; Disease Progression; Disease-Free Survival; Drug Evaluation; Female; Humans; Linoleic Acid; Lipoxygenase Inhibitors; Male; Middle Aged; Pancreatic Neoplasms; Thromboxane B2

2000

Other Studies

1 other study(ies) available for cv 6504 and thromboxane b2

ArticleYear
Synthesis and biological evaluation of 2,3,5-trimethyl-6-(3-pyridylmethyl)-1,4-benzoquinone (CV-6504), a dual inhibitor of TXA2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species (AOS).
    Advances in prostaglandin, thromboxane, and leukotriene research, 1991, Volume: 21A

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Antioxidants; Benzoquinones; Drug Design; Drug Evaluation, Preclinical; Free Radicals; Glomerulonephritis; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Molecular Structure; Oxygen; Puromycin Aminonucleoside; Rats; Structure-Activity Relationship; Thromboxane B2; Thromboxane-A Synthase

1991